Lupin trades with traction on the BSE

03 Jul 2014 Evaluate

Lupin is currently trading at Rs 1084.95, up by 12.20 points or 1.14% from its previous closing of Rs 1072.75 on the BSE.

The scrip opened at Rs 1078.00 and has touched a high and low of Rs 1098.60 and Rs 1055.45 respectively. So far 9924 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 2 has touched a 52 week high of Rs 1078.00 on 02-Jul-2014 and a 52 week low of Rs 742.30 on 28-Aug-2013.

Last one week high and low of the scrip stood at Rs 1078.00 and Rs 1015.25 respectively. The current market cap of the company is Rs 48517.84 crore.

The promoters holding in the company stood at 46.75% while Institutions and Non-Institutions held 43.17% and 10.08% respectively.

Lupin is planning to expand its footprint in Europe by acquiring generics manufacturers for as much as $1 billion. The company is eying those entities that are capable in complex generics like inhalation products and injectables, dermatology products and biosimilar drugs.

Europe is attractive because it has clearer regulations than the US on biosimilars, or copies of biotechnology therapies. Europe contributed 3 percent of Lupin’s sales last year.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.

 

Lupin Share Price

2166.10 -12.10 (-0.56%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×